University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
NCT Number: NCT01217658
Excessive infant crying (EIC) is likely to increase the risk of child abuse. The investigators propose a randomized trial using an intervention based on recommendations of Karp. The investigators will systematically identify 170 term infants with EIC and conduct assessments in the home at 6-8 weeks age to test the hypothesis that the intervention reduces mean infant hours of night-time crying, increases maternal soothing behaviors and improves parental anxiety and depression.
Looking for future studies?
Notify Me3 week–5 week
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Hypotheses: The soothing techniques taught to study parents 2-3 wks after birth augment parental soothing skills and reduces infant crying at night (primary outcome) and parental sleep loss, distress, & depression assessed in the home by a masked nurse at 8 wks.
Methods: Term singleton infants with EIC (> 3 hrs/24h) recruited through a program offered to parents at our hospital (4,700 births/yr) will be seen in our clinic 2-3 wks after birth. Consenting families (n=178) will be randomized to standard colic counseling (American Academy of Pediatrics) or to the intervention (adding nurse instruction plus a video and pamphlets). At 8 wks a study nurse will assess parental sleep and distress (Brief Symptom Inventory-18), place dosimeters in rooms where the infant sleeps and spends most time, and apply the actigraph at the ankle. She will collect the devices 5 days later, perform a physical exam at a usual feeding time (when EIC is likely), record infant & maternal behaviors during crying/feeding for the next 15 minutes using unobtrusive, validated methods (Tyson, 1992), and provide maternal support if desired. Standard statistical tests will be used (alpha=0.05; beta = 0.20; effect size =0.5 SD, power = .90).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Those receiving the intervention will be trained in the infant soothing techniques outlined in "The Happiest Baby on the Block".
Those receiving the control group allocation will be counseled using the American Academy of Pediatrics material for Infant Colic.
Time frame: 2 weeks after enrollment. Appproximately 6-8 weeks of life.
Objectively recording night-time duration of excessive crying
Time frame: 2 weeks after enrollment. Appproximately 6-8 weeks of life.
objectively measuring infant sleep duration
Time frame: At study entry and conculsion (4 week interval); 2 weeks after enrollment. Appproximately 6-8 weeks of life.
Using the BSI-18 at study enrollment and conclusion.
Time frame: At Study Entry and at 2 weeks after enrollment
We are collecting maternal salivary cortisol and amylase at study entry and at study conclusion (within 2 weeks after enrollment)
The University of Texas Health Science Center, Houston
Other
Measuring and Reducing Excessive Infant Crying: A Randomized Trial
Acronym: UTHealth THB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05271747
Colic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mexico City, Mexico
View Trial DetailsNCT06458881
Colic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Naples, Italy
View Trial DetailsNCT03467334
Colic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Granada, Spain
View Trial DetailsNCT02839239
Colic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
View Trial Details